BioNTech (NASDAQ:BNTX) said it has agreed to buy bispecific antibody developer Biotheus for up to $950M, including $150M in potential milestone payments. Under the deal, BioNTech (BNTX) will pay $800M ...
Nasdaq Staff determined that for the 10 consecutive business days between October 28 and November 11, 2024, the closing bid price of the Company’s ADSs has been at $1.00 per share or greater.
As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...
The determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nasdaq's equity requirement ...
The agreement calls for BioNTech to pay Biotheus shareholders $800 million, largely in cash along with some of its American depositary shares. It will then pay up to $150 million in additional ...
Under the terms of the agreement, BioNTech will pay Biotheus shareholders an upfront consideration of $800 million, predominantly in cash, with a small portion in American depositary shares (“ADS”), ...
Ryanair Holdings (RYAAY) has released an update. Ryanair Holdings has announced a share buyback, purchasing and canceling a total of 233,539 shares, including ordinary shares and those underlying ...
Based upon the closing bid price of the Company's American Depositary Shares ("ADSs") for the last 30 consecutive business days, the Company no longer meets this requirement. Normally, a company would ...
Shares of DoubleDown Interactive (DDI) are down about 4% today as Q3 revenue of $83.0 million and earnings of 51 cents per American depositary share (ADS) came in [...] ...